OverviewChartNewsTraderScreen

Turning Point Therapeutics/  US90041T1088  /

IEX
16/08/2022  22:02:15 Chg. - Volume Bid- Ask- High Low
76.01USD - 40,519
Turnover: 3.08 mill.		 -Bid Size: - -Ask Size: - 76.01 75.99
TeleTrader 11/04 Kishida: Ukraine of today may be East Asia of tomorrow
GlobeNewswire 30/08/2023 Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patien...
GlobeNewswire 29/03/2022 Turning Point Therapeutics Announces Appointment of Brian Sun, M.S., J.D., as Incoming General Couns...
GlobeNewswire 21/03/2022 Turning Point Therapeutics Announces Achievement of Enrollment Goal for TRIDENT-1 NTRK-Positive TKI-...
GlobeNewswire 11/03/2022 Colfax Announces Board of Directors for Enovis, the Post-Spinoff Medical Technology Company
GlobeNewswire 09/03/2022 Turning Point Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 07/03/2022 Turning Point Therapeutics to Participate in 42nd Annual Cowen Healthcare Conference - Update
GlobeNewswire 01/03/2022 Turning Point Therapeutics to Participate in 42nd Annual Cowen Healthcare Conference
GlobeNewswire 01/03/2022 Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021
GlobeNewswire 28/02/2022 Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Up...
GlobeNewswire 28/02/2022 Turning Point Therapeutics Reports Fourth-Quarter and Full Year 2021 Financial Results, Provides Ope...
GlobeNewswire 17/02/2022 Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China
GlobeNewswire 02/02/2022 Adagene Announces Board and Management Appointments to Support Pipeline Growth
GlobeNewswire 31/01/2022 Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer
GlobeNewswire 20/01/2022 Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for...
GlobeNewswire 18/01/2022 Turning Point Therapeutics Provides Updates and Anticipated 2022 Clinical and Discovery Pipeline Mil...
GlobeNewswire 18/01/2022 Syneos Health Appoints Two New Independent Directors
GlobeNewswire 20/12/2021 Turning Point Therapeutics Provides Regulatory Updates
GlobeNewswire 29/11/2021 Bright Peak Therapeutics Appoints Jacob Chacko, M.D., as Chair of its Board of Directors
GlobeNewswire 10/11/2021 View, Inc. Provides Update on Audit Committee Independent Investigation and 2021 Revenue Guidance
GlobeNewswire 09/11/2021 Turning Point Therapeutics Reports Third-Quarter Financial Results, Provides Operational Updates
GlobeNewswire 08/11/2021 Turning Point Therapeutics Announces Appointment of Adam Levy as Senior Vice President of Investor R...
GlobeNewswire 02/11/2021 Turning Point Therapeutics to Host Third Quarter 2021 Conference Call
GlobeNewswire 23/10/2021 Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study in Pediatr...
GlobeNewswire 13/10/2021 Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Comb...